Optic Nerve Stimulation To Prevent Visual Deficits After Endoscopic Cranial Approaches
Not Applicable
Not yet recruiting
- Conditions
- Skull Base NeoplasmsOptic Nerve InjuriesSellar Tumor
- Interventions
- Procedure: Optic Nerve Stimulation
- First Posted Date
- 2024-07-10
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 20
- Registration Number
- NCT06495580
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home
Recruiting
- Conditions
- HIV Infections
- Interventions
- Other: INVITE-HomeOther: Clinic-Administered LAI-ARTOther: Oral ART
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 1000
- Registration Number
- NCT06488846
- Locations
- 🇺🇸
Division of Prevention Science, Center for AIDS Prevention Studies (CAPS), San Francisco, California, United States
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
Phase 1
Not yet recruiting
- Conditions
- Stage IIIA Bladder Cancer AJCC v8Bladder CancerMuscle-Invasive Bladder CarcinomaStage II Bladder Cancer AJCC v8
- Interventions
- Drug: Enfortumab VedotinBiological: PembrolizumabRadiation: Intensity Modulated Radiation Therapy (IMRT)Procedure: Transurethral Resection of Bladder TumorProcedure: Cystoscopy (CS)Procedure: Computed Tomography (CT)Procedure: Magnetic Resonance Imaging (MRI)Procedure: Positron Emission Tomography (PET)
- First Posted Date
- 2024-06-24
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 47
- Registration Number
- NCT06470282
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Hybrid Effectiveness-Implementation Trial of a School Clinician Training and Psychosocial ADHD/ODD Intervention Program Adapted for Schools Across Mexico
Not Applicable
- Conditions
- ADHD
- Interventions
- Behavioral: CLS-A-FUERTE
- First Posted Date
- 2024-06-13
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 1000
- Registration Number
- NCT06457256
- Locations
- 🇲🇽
Benemérita Universidad Autónoma de Puebla, Puebla De Zaragoza, Puebla, Mexico
🇲🇽Universidad Autonoma de Sinaloa, Culiacán, Sinaloa, Mexico
🇺🇸UCSF, San Francisco, California, United States
Platelet Rich Plasma Injections In Young And Old Human Subjects
Phase 2
Not yet recruiting
- Conditions
- Musculoskeletal DisordersOsteoarthritisArticular Cartilage
- Interventions
- Drug: Platelet-Rich Plasma (PRP) InjectionsDevice: Centrifuge
- First Posted Date
- 2024-06-11
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 60
- Registration Number
- NCT06451120
- Locations
- 🇺🇸
University of California, San Francisco, California, United States
Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Phase 3
Not yet recruiting
- Conditions
- Tuberculosis, MDRTuberculosis, PulmonaryTuberculosis, Multidrug-Resistant
- Interventions
- Drug: Control Arm FQ-S MDR/RR-TB regimen, designed according to latest WHO guidelinesDrug: BedaquilineDrug: LinezolidDrug: PretomanidDrug: Moxifloxacin
- First Posted Date
- 2024-06-04
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 690
- Registration Number
- NCT06441006
- Locations
- 🇲🇩
Institute of Phthisiopneumology Chiril Dragniuc, Chisinau, Moldova, Republic of
🇲🇳National Center for Communicable Diseases, Ulaanbaatar, Mongolia
🇵🇪Hospital Nacional Hipólito Unanue, Lima, Peru
Levothyroxine Supplementation for Heart Transplant Recipients
Phase 1
Recruiting
- Conditions
- Heart Transplant FailureHeart Transplant Infection
- Interventions
- Drug: Normal salineDrug: Levothyroxine
- First Posted Date
- 2024-05-24
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 97
- Registration Number
- NCT06428097
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING PUMA)
Not Applicable
Not yet recruiting
- Conditions
- ART Adherence
- Interventions
- Behavioral: POC urine assay informed enhanced ART adherence counselling for viral suppression
- First Posted Date
- 2024-05-21
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 500
- Registration Number
- NCT06423612
- Locations
- 🇿🇦
Desmond Tutu HIV Foundation, East London, South Africa
Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP
Early Phase 1
Recruiting
- Conditions
- Sexually Transmitted Diseases, Bacterial
- Interventions
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 48
- Registration Number
- NCT06414408
- Locations
- 🇺🇸
University of California, San Francisco/San Francisco General Hospital, San Francisco, California, United States
Transforming Health and Reducing Perinatal Anxiety Through Virtual Engagement
Not Applicable
Suspended
- Conditions
- Anxiety
- Interventions
- Behavioral: Digital CBT
- First Posted Date
- 2024-05-08
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 132
- Registration Number
- NCT06404450
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
© Copyright 2025. All Rights Reserved by MedPath